Explore Prostatic Oncologists Around Houston
Explore physicians and researchers specializing in Prostate Cancer care, research, and innovation.
research
✳︎
innovation
✳︎
community
✳︎
research ✳︎ innovation ✳︎ community ✳︎
Dr. Guilherme Godoy, MD, MS
Dr. Guilherme Godoy is an Assistant Professor of Urology at the Baylor College of Medicine. He focuses on prostate, urothelial, and testicular cancers.
Phone: (713)-798-4001
For more info, click on the link below:
Dr. Feng Yang, PhD
Dr. Feng Yang is an Assistant Professor of Pathology and Immunology at the Baylor College of Medicine. His lab’s research focuses on MAPK4 biology in cancers, tumor microenvironments, and FGFR1 signaling in prostate and breast cancers.
Phone: (713)-798-8002
For more info, click on the link below:
Dr. Steve Canfield, MD
Dr. Steven Canfield is the Chief of Urology at Memorial Hermann - Texas Medical Center and is the Chair of Urology at McGovern Medical School at UTHealth in Houston.
Phone: (832)-325-7280
For more info, click on the link below:
Dr. Brian J. Miles, MD
Dr. Brian J. Miles is a physician specializing in Urologic Oncology at Houston Methodist. His clinical interests include Bladder, testicular, prostatic, and renal cancers.
Phone: (713)-441-6455
For more info, click on the link below:
Dr. Seth Paul Lerner, MD
Dr. Seth Paul Lerner is a Professor of Urology at Baylor College of Medicine. His main focuses are on bladder, prostate, and testis cancer(s).
Phone: (713)-818-9136
For more info, click on the link below:
Dr. Chinemerem Abanonu, MD
Dr. Chinemerem Abanonu is a physician specializing in Hematology/Oncology at Houston Methodist. His clinical interests include Prostate and lung cancers, and general oncological issues.
Phone: (832)-522-8521
For more info, click on the link below:
*PCRAD does not endorse or rank healthcare providers. Information is provided for educational and informational purposes only.
Questions to ask your Physician
What screening options are available?
What does my PSA level indicate?
Are there lifestyle changes that may improve outcomes?
How could treatment affect urinary, bowel, or sexual function?
Would genomic or biomarker testing help guide treatment?
Should I seek a second opinion from a prostate cancer specialist?

